T1	Treatment 0 24	MSL-109 adjuvant therapy
T2	Treatment 370 377	MSL-109
T3	Treatment 574 592	placebo-controlled
T4	Treatment 651 658	MSL-109
T5	Treatment 698 706	placebo.
T6	Treatment 806 826	Primary drug therapy
T7	Treatment 994 1009	MSL-109-treated
T8	Treatment 1044 1059	placebo-treated
T9	Treatment 1138 1153	MSL-109-treated
T10	Treatment 1379 1394	MSL-109-treated
T11	Treatment 1434 1449	placebo-treated
T12	Treatment 1794 1809	MSL-109-treated
T13	Treatment 1845 1853	(MSL-109
T14	Treatment 1873 1880	placebo
T15	Treatment 1944 1959	placebo-treated
T16	Treatment 2185 2192	MSL-109
T17	Treatment 2315 2330	MSL-109-treated
